Direct delivery of an investigational cell therapy in patients with Parkinson’s disease: an interim analysis of feasibility and safety of an open-label study using DBS-Plus clinical trial design

OBJECTIVE: To evaluate the interim feasibility, safety and clinical measures data of direct delivery of regenerating peripheral nerve tissue (PNT) to the substantia nigra (SN) in participants with Parkinson’s disease (PD). METHODS: Eighteen (13 men/5 women) participants were unilaterally implanted w...

Descripción completa

Detalles Bibliográficos
Autores principales: Quintero, Jorge E, Slevin, John T, Gurwell, Julie A, McLouth, Christopher J, El Khouli, Riham, Chau, Monica J, Guduru, Zain, Gerhardt, Greg A, van Horne, Craig G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295654/
https://www.ncbi.nlm.nih.gov/pubmed/35949912
http://dx.doi.org/10.1136/bmjno-2022-000301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295654/
https://www.ncbi.nlm.nih.gov/pubmed/35949912
http://dx.doi.org/10.1136/bmjno-2022-000301

Ejemplares similares